KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,308 | -74.3% | 637 | -67.6% | 0.00% | -66.7% |
| Q2 2023 | $78,994 | +164470.8% | 1,966 | +72.5% | 0.00% | +50.0% |
| Q1 2023 | $48 | +108.7% | 1,140 | +134.6% | 0.00% | +100.0% |
| Q4 2022 | $23 | -100.0% | 486 | -82.9% | 0.00% | -50.0% |
| Q3 2022 | $107,000 | +7.0% | 2,843 | -21.7% | 0.00% | 0.0% |
| Q2 2022 | $100,000 | +376.2% | 3,632 | +863.4% | 0.00% | – |
| Q1 2022 | $21,000 | -78.6% | 377 | -77.5% | 0.00% | -100.0% |
| Q4 2021 | $98,000 | +415.8% | 1,677 | +246.5% | 0.00% | – |
| Q3 2021 | $19,000 | -55.8% | 484 | -52.1% | 0.00% | -100.0% |
| Q2 2021 | $43,000 | +22.9% | 1,010 | +79.7% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | +150.0% | 562 | +192.7% | 0.00% | – |
| Q4 2020 | $14,000 | -94.3% | 192 | -97.0% | 0.00% | -100.0% |
| Q3 2020 | $247,000 | +1800.0% | 6,399 | +1744.1% | 0.00% | +200.0% |
| Q2 2020 | $13,000 | – | 347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |